IL-10 derived from Hepatocarcinoma cells improves human induced regulatory T cells function via JAK1/STAT5 pathway in tumor microenvironment.

MLA

Zhang, Shaopeng, et al. “IL-10 Derived from Hepatocarcinoma Cells Improves Human Induced Regulatory T Cells Function via JAK1/STAT5 Pathway in Tumor Microenvironment.” Molecular Immunology, vol. 133, May 2021, pp. 163–72. EBSCOhost, https://doi.org/10.1016/j.molimm.2021.02.014.

APA

Zhang, S., Gan, X., Qiu, J., Ju, Z., Gao, J., Zhou, J., Shi, C., Zhu, Y., & Li, Z. (2021). IL-10 derived from Hepatocarcinoma cells improves human induced regulatory T cells function via JAK1/STAT5 pathway in tumor microenvironment. Molecular Immunology, 133, 163–172. https://doi.org/10.1016/j.molimm.2021.02.014

Chicago

Zhang, Shaopeng, Xiaojie Gan, Jiannan Qiu, Zheng Ju, Ji Gao, Jinren Zhou, Chengyu Shi, Yaqing Zhu, and Zhang Li. 2021. “IL-10 Derived from Hepatocarcinoma Cells Improves Human Induced Regulatory T Cells Function via JAK1/STAT5 Pathway in Tumor Microenvironment.” Molecular Immunology 133 (May): 163–72. doi:10.1016/j.molimm.2021.02.014.